Application progress of 18F-FDG PET/CT in the diagnosis and treatment of gastrointestinal stromal tumors

VernacularTitle:18F-FDG PET/CT在胃肠间质瘤诊疗中的应用进展
Author: Wenhui ZHOU ¹ ; Xun SUN ; Rui AN
Author Information

1. 华中科技大学同济医学院附属协和医院核医学科
Keywords: Gastrointestinal neoplasms; Positron-emission tomography; Tomography,X-ray computed; Deoxyglucose; Trends
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2018;38(3):214-217
CountryChina
Language:Chinese
Abstract: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract.It can be classified as benign,malignant potential undetermined and malignant according to their biological behaviors.Early diagnosis,accurate staging and therapeutic response evaluation have an effect on the clinical decision-making and prognosis.Those factors used to be assessed by traditional imaging techniques,such as CT,EUS and MRI.While 18F-fluorodeoxyglucose (FDG) PET/CT,combining the advantages of both anatomic information from CT and functional information from PET,plays a considerable role in the diagnosis,staging,clinical decision-making,response evaluation,prognosis and recurrence detection of GIST.Consequently,18F-FDG PET/CT will be helpful to guide the personalized treatment of GIST.This review introduces the application progress of 18F-FDG PET/CT in GIST.